How to bill for discontinued vasectomy procedure
Can urologists find gold in Advanced APMs?
How will urologists fare under 2018 MIPS rule?
Does shock wave therapy have a future in the treatment of ED?
How profit enters the product development equationAfter attending an industry dinner, urologist Henry Rosevear, MD, came away with an appreciation for the role of health care economics in bringing a product to market.
QPP implementation: CMS has begun to listenWhile CMS has demonstrated an ability to listen to providers’ concerns about QPP implementation, many issues still need to be addressed and urologists must continue to be vocal.
How to choose the best retirement savings planThere are several options for saving for retirement, but first develop a good understanding of how these retirement accounts work to get the most out of your savings.
Model unable to identify focal therapy candidatesThe development of a model for identifying prostate cancer patients who may be appropriate candidates for hemi-ablative focal therapy remains a work in progress for researchers at Memorial Sloan Kettering Cancer Center.
Smoking linked to tumor heterogeneity for bladder CaResearchers from Wake Forest Baptist Comprehensive Cancer Center have made novel discoveries about the genomic signatures of cancers—including bladder cancer—in smokers and African-American patients.
Genomic research may explain resistance to immunotherapyNew research characterizing the molecular mechanisms regulating immune cell infiltration into the luminal subtype of muscle-invasive bladder cancer may explain resistance to treatment with immune checkpoint blockade and suggest a target for improving therapeutic response.


View Results